PubRank
Search
About
Clara Alsinet
Author PubWeight™ 31.15
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
Cancer Res
2008
4.35
2
Pivotal role of mTOR signaling in hepatocellular carcinoma.
Gastroenterology
2008
4.03
3
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.
Gastroenterology
2011
2.66
4
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
J Hepatol
2009
2.42
5
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.
Gastroenterology
2013
2.42
6
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a.
Gastroenterology
2011
1.77
7
Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice.
Gastroenterology
2012
1.71
8
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
J Hepatol
2010
1.66
9
New strategies in hepatocellular carcinoma: genomic prognostic markers.
Clin Cancer Res
2010
1.46
10
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
Clin Cancer Res
2012
1.44
11
Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.
J Hepatol
2012
1.26
12
Gene signatures in the management of hepatocellular carcinoma.
Semin Oncol
2012
1.02
13
Molecular approaches to treatment of hepatocellular carcinoma.
Dig Liver Dis
2010
1.01
14
VEGF signaling in cancer treatment.
Curr Pharm Des
2014
0.91
15
Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR.
Hepatology
2012
0.88
16
Molecular pathogenesis of hepatocellular carcinoma.
Alcohol Clin Exp Res
2011
0.84
17
One patient, two lesions, two oncogenic drivers of gastric cancer.
Genome Biol
2014
0.75
18
microRNAs and the MYC network: a major piece in the puzzle of liver cancer.
Gastroenterology
2011
0.75
19
Oncolytic immunotherapeutic virus in HCC: can it compete with molecular therapies?
J Hepatol
2013
0.75
20
Genetically engineered mouse models: future tools to predict clinical trial results in oncology?
Future Oncol
2013
0.75